Cue Biopharma, Inc. (CUE) is a publicly traded Healthcare sector company. As of November 16, 2026, CUE trades at $14.17 with a market cap of $117.10M and a P/E ratio of -0.80. CUE moved -11.76% today. Year to date, CUE is +39.99%; over the trailing twelve months it is -25.03%. Its 52-week range spans $4.97 to $45.50. Analyst consensus is buy with an average price target of $83.00. Rallies surfaces CUE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for CUE shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $14.17 |
| Market Cap | $117.10M |
| P/E Ratio | -0.80 |
| EPS | $-28.43 |
| Dividend Yield | 0.00% |
| 52-Week High | $45.50 |
| 52-Week Low | $4.97 |
| Volume | 203.20K |
| Avg Volume | 0 |
| Revenue (TTM) | $37.65M |
| Net Income | $-164.11M |
| Gross Margin | 0.00% |
1 analysts cover CUE: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $83.00.